375. An evaluation of routine HIV screening in an urban hospital setting.
Session: Poster Abstract Session: HIV Epidemiology: Screening and Testing - Outpatient to Inpatient
Thursday, October 8, 2015
Room: Poster Hall
Background: In April 2013, the U.S. Preventative Service Task Force released revised guidelines in concordance with the CDC, recommending that all persons age 15-65 should be routine screening for HIV with increased frequency of screening for individuals in high prevalence settings. We evaluated the University Hospital medicine inpatient service to determine the rate at which eligible patients were screened for HIV.

Methods: A retrospective chart review was performed on 400 patients admitted to the medicine service at University Hospital from December 1st, 2014- December 25th, 2014. Patients were evaluated for known history of HIV, documented prior HIV screening, and whether screening was performed during the current admission.  If screened during admission, the ordering physician's service was recorded.  Patients considered eligible for screening were those without a documented history of HIV or HIV screening test greater than 12 months prior to admission.

Results: A total of 400 admissions were reviewed of which 31 had a prior history of HIV and 65 were screened for HIV in the prior 12 months. 179 patients (45%, 95% CI= 40-50%) had no documented lifetime HIV screening history. 304 patients were considered eligible for screening however only 69 (23%, 95% CI= 18%-27%) were screened during the course of their admission.

Conclusion: Adherence to HIV screening guidelines continues to be a challenge in the urban hospital setting even in admitted patients, as evidenced by this study showing only 23% of patients eligible for HIV screening were tested during the course of their admission.  In 2013, the HIV prevalence of Newark was over 3% and so it remains critical that no opportunities for screening patients are missed.

Aileen Tlamsa, MD, Internal Medicine, Rutgers-New Jersey Medical School, Newark, NJ, Jason Zucker, MD, Medicine and Pediatrics, Rutgers New Jersey Medical School, Newark, NJ and David Cennimo, MD, Internal Medicine and Pediatrics, Rutgers New Jersey Medical School, Newark, NJ

Disclosures:

A. Tlamsa, None

J. Zucker, None

D. Cennimo, None

Previous Abstract | Next Abstract >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.